Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial

May Ee Png, Victoria Harris, Jenna Grabey, Nigel David Hart, Bhautesh Dinesh Jani, Daniel Butler, Andrew Carson-Stevens, Maria Coates, Lucy Cureton, Melissa Dobson, Jienchi Dorward, Philip Evans, Nick Francis, Oghenekome Abisoye Gbinigie, Gail Hayward, Jane Holmes, Kerenza Hood, Saye Khoo, Haroon Ahmed, Mark LownMicheal Mckenna, Sam Mort, Jonathan Nguyen-Van-Tam, Najib Rahman, Duncan B Richards, Nicholas Thomas, Oliver van Hecke, FD Richard Hobbs, Paul Little, Ly-mee Yu, Christopher C. Butler, Stavros Petrou

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial'. Together they form a unique fingerprint.

Medicine and Dentistry